NLRP3-IN-41 - CAS 1209698-02-1

NLRP3-IN-41 administered at doses of 40 and 80 mg/kg through intragastric (i.g.) delivery over a span of 10 days, successfully alleviated the symptoms of colitis induced by DSS in both C57BL/6 and ICR mice.

Others, NOD-like Receptor (NLR)

Immunology/Inflammation, Others

1209698-02-1

C22H22N2O4S2

442.55

O=S(=O)(NC1=CC=C2C(=C1)N(CCC2)S(=O)(=O)C)C=3C=CC(=CC3)C=4C=CC=CC4

-20°C

Ice Packs

Small Compound